
Ruilin Tian
Articles
-
Oct 25, 2024 |
tandfonline.com | Ruilin Tian |Limin Zhang |Jeffrey Chen
ABSTRACTThis paper examines the de-risking behaviour of defined benefit (DB) pension plans sponsored by U.S. firms. By analysing a range of strategies used in U.S. markets between 1994 and 2018, such as plan shifts, freezes, terminations, buyouts, buyins, and longevity hedges, we identify the key drivers and outcomes of pension de-risking.
-
May 23, 2024 |
mdpi.com | Yitong Fang |Xing LI |Ruilin Tian
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Apr 10, 2024 |
preprints.org | Yitong Fang |Xing LI |Ruilin Tian
Preprint Review Version 1 This version is not peer-reviewed Version 1 : Received: 9 April 2024 / Approved: 10 April 2024 / Online: 10 April 2024 (08:14:36 CEST) Fang, Y.; Li, X.; Tian, R. Unlocking glioblastoma vulnerabilities with CRISPR-based genetic screening. Preprints 2024, 2024040711. https://doi.org/10.20944/preprints202404.0711.v1 Fang, Y.; Li, X.; Tian, R. Unlocking glioblastoma vulnerabilities with CRISPR-based genetic screening. Preprints 2024, 2024040711.
-
Nov 5, 2023 |
nature.com | Jun-Tao Zhang |Ruilin Tian
AbstractArgonaute proteins (Agos), which use small RNAs or DNAs as guides to recognize complementary nucleic acid targets, mediate RNA silencing in eukaryotes. In prokaryotes, Agos are involved in immunity: the short prokaryotic Ago/TIR–APAZ (SPARTA) immune system triggers cell death by degrading NAD+ in response to invading plasmids, but its molecular mechanisms remain unknown.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →